News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...

INTERMUNE: Pulmonary Fibrosis Drug Will Open the Door to A large Product Pipeline

  Thursday, March 11, 2010
The FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbiet® (pirfenidone) developed by the biotech firm Intermune (ITMN) for idiopathic pulmonary fibrosis (IPF). The same drug is approved in Japan for IPF and sold under the trade name Pirespa® by Shionogi in that country. Both Intermune and Shionogi had licensed pirfenidone from Marnac and its co-licensor, KDL GmbH.  More...

Recent Postings



Mirati Therapeutics (MRTX) PTC Therapeutics (PTCT) AstraZeneca (AZN) CompuGen (CGEN) Benlysta (belimumab) Global Cell Therapeutics (GBT) ISIS (ISIS) Idenix (IDIX) Roche (RHHBY) Human Genome Sciences (HGSI) SYNTA (SNTA) Tysabri Sanofi (SNY) Anacor (ANAC) Sanofi (SNA) ACADIA (ACAD) Spike Therapeutics (ONCE) Roche (ROCHE) Revlimid (lenolidamide) Cytokinetics (CYTK) ARGOS (ARGS) ABBVIE (ABBV) GlaxoSmithKline (GSK) Gilead (GILD) Genentech KERYX (KERX) Biogen Idec (BIIB) Merck (MRK) Ziofpharm (ZIOP) JOUNCE THERAPEUTICS (JNCE) NOVOCURE (NVCR) Auspex (ASPX) ImmunoGen (IMGN) PORTOLA (PTLA) Advaxis (ADXS) Elan (ELN) Biocryst (BCRX) Herceptin Onyx (ONXX) NEKTAR (NKTR)) Abbott Laboratories (ABT) GUARDIAN HEALTH Sarepta (SRPT) Agenus (AGEN Seattle Genetics (SGEN) OncoCyte (OCX) Endometrial Cancer AGOS (ARGS) Prosensa (RNA) Xoma (XOMA) Intermune (ITMN) Vitae Pharmaceuticals (VTAE) Valeant Pharmaceuticals International (VRX) MODERNA Dynavax (DVAX) Illumina (ILMN) KITE (KITE) Zerenex Anadys (ANDS) Galena (GALE) Aimmune Therapeutics (AIMT) IDERA (IDRA) NANTKWEST (NK) TOKAI (TKAOI) Prolor Biotech (PBTH) Rapamune Multiple Myeloma Inovio (INO) Sanofi-Aventis (SAN) ARCA (ABIO) Ocular Therapeutix (OCUL) Theravance Bio Pharma (TBPH) Ionis (IONS) Jazz Pharmaceuticals (JAZZ) JUNO (JUNO) Agenus (AGEN) Array Pharmaceuticals (ARRY) Sangamo (SGMO) Bristol-Myers Squibb (BMY) Alnylam (ALNY) Pluristem (PSTI) LEXICON (LXRX) Telaprevir Ridaforolimus Human Longevity (HLI) BIOMARIN (BMRN) Adaptimmune (ADAP) Sequenom (SQNM) VANDA (VNDA) Incyte (INCY) SUNESIS PHARMACEUTICALS (SNSS) Amgen (AMGN) Regeneron (REGN) Micromet (MITI) Editas (EDIT) NEUROCRINE (NBIX) Dendreon (DNDN) Velcade (bortezomib) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) Alder Biopharmaceuticals (ALDR) Vertex (VRTX) OSI (OSIP) REGULUS (RGLS) ZALTRAP™ CEMPRA (CEMP) Exelixis (EXEL) Intercept (ICPT) Trastuzumab-DM1 galapagos (GLPG) RenenxBio (RGNX) Intrexon (XON) AERIE PHARMACEUTICALS C4 Therapeutics ADVENTRIX (ANX) Theravance (THRX) Ariad (ARIA) CRISPR Therapeutics (CRSP) Bellicum (BLCM) INNOVIVA (INVA)